The Best in Science News and Amazing Breakthroughs
An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trialThe drug amycretin caused people to lose 13 percent of their body weight over three months, according to the results of a phase one trial announced by the company.
Nonetheless, the announcement at an investor event on Thursday sent Novo Nordisk's shares shooting up more than eight percent. "This approach seems to be a little bit more exciting, from the limited data that we have," Daniel Drucker, a researcher at the Canada's University of Toronto, told New Scientist.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Experimental weight loss pill seems to be more potent than OzempicTaking the oral pill amycretin resulted in people losing 13 per cent of their body weight over three months, more than twice that seen with Ozempic, but larger and longer studies are needed
Read more »
Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drugLars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.
Read more »
New Weight Loss Pill More Effective Than Ozempic, Tests FindScience and Technology News and Videos
Read more »
New Weight-Loss Drug Amycretin Has Patients Losing 13% of Body Weight in Just 3 MonthsDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Read more »
Novo Nordisk market cap surpasses Tesla on new obesity pill trial dataWegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday after fresh early trial data showed positive results for its new experimental weight loss pill.
Read more »
Beyond Wegovy: Could the next wave of weight-loss drugs end obesity?Wegovy and Ozempic have made headlines, but a new wave of more effective drugs like Mounjaro have the potential to end obesity altogether. How will they work and are they safe?
Read more »